Related Experiment Video
Updated: Oct 31, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Role of epigenetic regulation in myocardial ischemia/reperfusion injury
Keyan Wang1, Yiping Li1, Tingting Qiang1
1Cardiovascular Research Institute of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China,; Cardiovascular Department of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Branch of National Clinical Research Center for Chinese Medicine Cardiology, Shanghai 201203, China.
Insights
Acute myocardial infarction (AMI) treatment can cause reperfusion injury. Epigenetic mechanisms like histone modification and DNA methylation offer new therapeutic targets for preventing this injury.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Epigenetics
Background:
- Acute myocardial infarction (AMI) is a leading global cause of death.
- Reperfusion therapy is crucial for AMI but can induce myocardial ischemia/reperfusion injury.
- Currently, no effective treatments exist for myocardial ischemia/reperfusion injury.
Purpose of the Study:
- To review the role of epigenetic modifications in myocardial ischemia/reperfusion injury.
- To explore potential therapeutic targets for mitigating reperfusion injury.
- To provide insights for future research and clinical interventions.
Main Methods:
- Literature review focusing on epigenetic mechanisms.
- Analysis of studies on histone modification, DNA methylation, noncoding RNAs, and m6A methylation.
- Synthesis of current understanding of epigenetics in myocardial ischemia/reperfusion injury.
Main Results:
- Epigenetic regulation, including histone modification, DNA methylation, noncoding RNAs, and m6A methylation, is implicated in the pathogenesis of myocardial ischemia/reperfusion injury.
- These epigenetic changes contribute to the cellular damage and dysfunction following reperfusion.
- Targeting these epigenetic pathways presents a promising therapeutic strategy.
Conclusions:
- Epigenetic mechanisms play a significant role in myocardial ischemia/reperfusion injury.
- Targeting epigenetic modifications offers a novel therapeutic avenue for treating and preventing reperfusion injury after AMI.
- Further research into these pathways could lead to improved clinical outcomes for AMI patients.
Abstract:
Nowadays acute myocardial infarction (AMI) is a serious cardiovascular disease threatening the human life and health worldwide. The most effective treatment is to quickly restore coronary blood flow through revascularization. However, timely revascularization may lead to reperfusion injury, thereby reducing the clinical benefits of revascularization. At present, no effective treatment is available for myocardial ischemia/reperfusion injury. Emerging evidence indicates that epigenetic regulation is closely related to the pathogenesis of myocardial ischemia/reperfusion injury, indicating that epigenetics may serve as a novel therapeutic target to ameliorate or prevent ischemia/reperfusion injury. This review aimed to briefly summarize the role of histone modification, DNA methylation, noncoding RNAs, and N6-methyladenosine (m6A) methylation in myocardial ischemia/reperfusion injury, with a view to providing new methods and ideas for the research and treatment of myocardial ischemia/reperfusion injury.
Related Concept Videos
Myocarditis I: Introduction
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

